← Research hub  ·  securities

WES · Western Midstream Partners $47.31 +0.15 (+0.32%) 2026-SEP-18 12:47 EST

My allocation$44,6150.99% of portfolio1 account · as of 2026-SEP-03 · allocation page ↗
AccountSharesPriceValue% of acctCost/shGain $Gain %Target
RLT907$49.19$44,6152.66%$39.42$8,859+24.8%
Research: QT · SA · STK · FA2 mentions
2026-JUN-09 · James Davolos · In the Money with Amber Kanwar · Neutralmention · ▶ 49:45 · source page ↗$44.21

In short: The large gas-gathering system that acquired Aris at $25 — Aris chose to merge in rather than fight for scale.

49:45When you recommended it was trading around 23 bucks. It got taken out by Western Midstream Partners at $25. Tell me about Did you like that deal? What's going on with water in general? — The thesis with water is I think it's pretty simple. The Permian Basin is almost perhaps the most important reservoir in global oil supply and demand balances.

SOD $44.21
2026-JAN-08 · Cole Smead · In the Money with Amber Kanwar (YouTube podcast) · Neutralmention · ▶ 56:38 · source page ↗$39.75

In short: Reference — the midstream business Oxy owns 40% of, "doing just fine at multi-year highs." The asset Smead thinks Oxy should monetize to fund buybacks — a live example of his sell-the-hedged-asset, keep-the-oil-beta capital-allocation view.

56:38They own 40% of that business. Well, if you go look at the midstream business right now, their stock prices haven't moved at all. They're doing just fine at multi-year highs, I think, in Western Midstream stock case. But if I have $6.4 billion in a mid-stream business that is doing fine right now, wouldn't I want to sell that midstream business and go out and reinvest that either in my own stock in a buyback or by just reducing my capital structure and returning that to shareholders in some way? I would. And

SOD $39.75

Nothing matches this filter.

Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.